Focus on Anticoagulation Care

Back to articles

Dabigatran versus warfarin for atrial fibrillation

KEY POINT

Rates of ischemic stroke and extracranial hemorrhage were similar for patients with atrial fibrillation (AF) using dabigatran (Pradaxa—Boehringer Ingelheim) or warfarin; however, dabigatran use resulted in significantly lower rates of intracranial bleeding and higher rates of myocardial infarction (MI), according to results of a retrospective cohort study published in the Annals of Internal Medicine.